Rajan Sharma
Stock Analyst at Goldman Sachs
(0.07)
# 4,503
Out of 5,124 analysts
5
Total ratings
25%
Success rate
-41.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $19.17 | -62.18% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $91.93 | +5.52% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $49.04 | -4.16% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $34.60 | +128.32% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $19.17
Upside: -62.18%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $91.93
Upside: +5.52%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $49.04
Upside: -4.16%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $34.60
Upside: +128.32%